Product Information
EDLUAR 10 MG SL TABLET is a brand product labeled by Viatris Specialty LLC, priced at $15.4839 per EA under NDC 00037601093. Its NADAC has been published 213 times since Sep 7, 2022.
FDA first approved this application on Mar 13, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Zolpidem Tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Viatris Specialty LLCNDC
00037601093
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA021997FDA Approved
3/13/2009
TE Code
AB
On Market Since
7/24/2009
Pharmacological Classes
Price Statistics
The NADAC for EDLUAR 10 MG SL TABLET has been published 213 times since Sep 7, 2022, and over the history we have for it it has risen 24.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.4839 per EA |
|---|---|
| All-time high | $15.5942 (Jun 10, 2026) |
| All-time low | $12.4177 (Sep 7, 2022) |
| 52-week high | $15.5942 |
| 52-week low | $14.8160 |
| Median price | $14.1406 |
| Average price | $14.1802 |
| Largest weekly change | +7.0% (Jan 11, 2023) |
| Weeks tracked | 213 |
| Tracking since | Sep 7, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolpidem Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid A Receptor Positive Modulator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EDLUAR 10 MG SL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EDLUAR 10 MG SL TABLET, manufactured by Viatris Specialty LLC, is $15.4839 per EA (NDC 00037601093), effective Sep 30, 2026.
How has the price of EDLUAR 10 MG SL TABLET changed over time?
Over the history we have for it, the NADAC for EDLUAR 10 MG SL TABLET has risen 24.7%. It has been tracked across 213 weekly CMS publications since Sep 7, 2022.
What are the highest and lowest recorded NADAC prices for EDLUAR 10 MG SL TABLET?
Since Sep 7, 2022, the NADAC for EDLUAR 10 MG SL TABLET has ranged from a low of $12.4177 (Sep 7, 2022) to a high of $15.5942 (Jun 10, 2026), with a median of $14.1406 per EA.
Are there cheaper alternatives to EDLUAR 10 MG SL TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLPIDEM TARTRATE 10 MG TABLET, is $0.0271 per EA — about 99% below EDLUAR 10 MG SL TABLET.
Who manufactures EDLUAR 10 MG SL TABLET?
EDLUAR 10 MG SL TABLET (NDC 00037601093) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.